More on PDSB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+36.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PDS Biotechnology (NQ:PDSB)
Delayed: 1.13 -0.17 (13.08%)
Prev. Close $1.30  
Open$1.25 
52 Wk High$ 
52 Wk Low$ 
Day High$1.26 
Day Low$1.09 
P/E N/A  
EPS$ 
Volume6,934,226 

Friends, Peers and Foes (?): IBRX NH (more...)

Oct 14, 2026 04:17 PM Form S-3 PDS Biotechnology Corp
Oct 6, 2026 08:06 AM Form 8-K PDS Biotechnology Corp For: Oct 06
Oct 6, 2026 08:00 AM PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
Sep 22, 2026 05:10 PM Form 8-K PDS Biotechnology Corp For: Sep 12
Sep 22, 2026 08:05 AM Form 8-K PDS Biotechnology Corp For: Sep 22
Sep 22, 2026 08:00 AM PDS Biotech publishes phase 2 head and neck cancer trial results
Sep 22, 2026 08:00 AM PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncolog
Sep 21, 2026 09:56 PM Form SCHEDULE 13D PDS Biotechnology Corp Filed by: Nant Capital, LLC
Sep 21, 2026 08:40 PM Form 3 PDS Biotechnology Corp For: Sep 14 Filed by: SOON-SHIONG PATRICK
Sep 21, 2026 08:39 PM Form 3 PDS Biotechnology Corp For: Sep 14 Filed by: Banaag Arnold James
View All Articles

Entities mentioned with PDSB

View All Entities